Clinical Trial Update: CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a planned Phase 1/2 study of inhaled caspofungin (Caspofungin aerosols) for the curative treatment of Pneumocystis pneumonia, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumocystis Pneumonia

Drugs mentioned

• Caspofungin (caspofungin)

Snippet

Sponsor: University Hospital, Tours | Conditions: Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING